Govindarajan Narayanan, chief of interventional oncology at Miami Cancer Institute and a vascular interventional radiologist with Miami Cardiac & Vascular Institute (both Miami, USA), successfully treated the first patient in the USA with a liver tumour using Quantum Surgical’s Epione robot. The procedure took place at Baptist Health South Florida (Miami, USA) a few days after the US Food and Drug Administration (FDA) cleared Epione robot for treatment of all abdominal cancers.
Quantum Surgical’s flagship product, the Epione robotic platform, is dedicated to the curative treatment of cancers. Epione allows physicians to treat inoperable tumours that are particularly difficult to reach, due to their size or their location, at an early stage, in a simple and effective way. More than 150 patients have already been treated with the Epione robot in Europe, and Narayanan successfully treated the first patient in the USA.
“I am honoured to be the first physician to utilise Epione in the USA as this robotic-assisted equipment is going to change the way we deliver effective treatments to our patients for cancerous tumours,” said Narayanan. “Baptist Health has always been at the forefront when it comes to providing the very best care to the South Florida community and beyond. I am proud to be a part of such an incredible team.”
Bertin Nahum, president and co-founder of Quantum Surgical stated in a press release: “We are very proud of this first intervention with our Epione robot in the USA. We are delighted to have been able to work with Narayanan and Baptist Health South Florida. This first intervention coincides with the US FDA extension clearance to deploy our robotic solution in the USA. Dr Narayanan is paving the way for physicians who will be able to offer more patients to benefit from innovative and less invasive treatments, and improve their lives.”
Epione is a robot-assisted technology designed to plan, target, perform and confirm tumour ablation. Epione enables physicians to perform percutaneous tumour ablations, a minimally invasive treatment in which one or more needles are inserted through the skin into the tumour to destroy it.